Sodium Phosphate

Indications
Oral
Hypophosphataemia
Adult: Up to 100 mmol of phosphate daily.
Renal impairment: Dose reduction may be necessary.
Intravenous
Severe hypophosphataemia
Adult: As monobasic potassium phosphate: Up to 9 mmol of phosphate given over 12 hr, repeat 12 hrly if needed. Alternatively, 0.2-0.5 mmol/kg phosphate (max: 50 mmol), may be given over 6-12 hr.
Rectal
Mild osmotic laxative for bowel evacuation and cleansing
Adult: Usually contains monobasic and dibasic sodium phosphates but the composition and dosage may vary. Phosphate enemas work within 2-5 minutes. Use as directed.
Renal impairment: Dose reduction may be necessary.

Special Populations: Reduce doses in patients with renal function impairment.

Incompatibility: Incompatible with calcium salts.
Contraindications
Severe renal function, congestive heart failure, ascites, unstable angina pectoris, gastric retention, ileus or acute obstruction or pseudo-obstruction, severe chronic constipation, bowel perforation, acute colitis, toxic megacolon or hypomotility syndrome, hypertension, hyperkalaemia, oedema, low serum-calcium concentrations, infected phosphate renal calculi.
Warnings / Precautions
Chronic renal disease, pre-existing electrolyte disturbances. Concurrent admin with drugs that may affect electrolyte levels. Correct electrolyte abnormalities before initiating therapy. Monitor renal function, serum calcium, serum phosphorus, serum potassium, and serum sodium at periodic intervals during therapy. Caution in patients taking drugs that may prolong QT interval. Ensure adequate hydration. Pregnancy. Elderly or debilitated patients.
Adverse Reactions
Abdominal discomfort or pain, diarrhoea, nausea, vomiting, hypernatraemia, dehydration (with high doses). Convulsions, drowsiness, mood change, trembling, malaise, loss of appetite, muscle spasm (with long-term use). Less frequently, headaches, dizziness, mental confusion, seizures, weakness or heaviness of legs, muscle cramps, numbness, tingling, pain, arrhythmia; shortness of breath or troubled breathing; swelling of lower legs or feet; unusual weight gain, low urine output; unusual thirst; bone and joint pain.
Overdose Reactions
May lead to severe electrolyte disturbances, including hyperphosphataemia, hypocalcaemia, hypernatraemia, or hypokalaemia, as well as dehydration and hypovolaemia. May also lead to cardiac arrhythmias, seizure, renal failure and death. Monitor carefully and treat symptomatically until stable.
Drug Interactions
Concurrent use with aluminium, calcium, or magnesium salts will reduce absorption of phosphates. Vitamin D increases the GI absorption of phosphates and risk of hyperphosphataemia. Increased risk of hyperphosphataemia, hypocalcaemia, and hypernatraemia when used in patients receiving diuretics or drugs that may affect serum electrolytes. Increased risk of ectopic calcification when used concurrently with calcium supplements or calcium-containing antacids.
See Below for More sodium phosphate Drug Interactions
Food Interactions
Decreased effects with milk or dairy products due to their calcium content.
Mechanism of Actions
Sodium phosphate can be used in the management of hypophosphataemia. It also acts as a mild osmotic laxative when given orally as dilute solutions or by the rectal route. Phosphate enemas or concentrated oral solutions are used for bowel cleansing before surgery or endoscopy procedures.
Absorption: About 66% of an oral dose is absorbed from the GI tract.
Metabolism:
Excretion: Mainly excreted in the urine with the remaining dose via the faeces.
Storage Conditions
Oral: Store at 15-30°C. Rectal: Store at 15-30°C.
ATC Classification
A06AD17 - sodium phosphate ; Belongs to the class of osmotically acting laxatives.
A06AG01 - sodium phosphate ; Belongs to the class of enemas. Used in the treatment of constipation.
B05XA09 - sodium phosphate ; Belongs to the class of electrolyte solutions used in I.V. solutions.
Storage
Oral: Store at 15-30°C. Rectal: Store at 15-30°C.
Available As
  • Sodium Phosphate 0.1%
  • Sodium Phosphate 0.1% w/v
  • Sodium Phosphate 0.42 mg
  • Sodium Phosphate 0.975%
  • Sodium Phosphate 10 mg
  • Sodium Phosphate 16% w/v
  • Sodium Phosphate 18 mg
  • Sodium Phosphate 6 gm
  • Sodium Phosphate 6% w/v
  • Subscribe for latest updates

    Subscribe to our e-mail newsletter to receive updates.

    No comments yet.

    Post Review about Sodium Phosphate


    Drug - Drug Interactions of Sodium Phosphate

    We are Developing Our database, More results coming soon.